Skip to main content
Loading ResearchHub…
References for Clinical and economic benefits of bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for prevention of RSV in adults: a cost-effectiveness analysis for Singapore | ResearchHub - ResearchHub